Roflumilast A PDE4 Inhibitor for COPD and Asthma Treatment Roflumilast A PDE4 Inhibitor for COPD and Asthma Treatment Introduction to Roflumilast Roflumilast is classified as a phosphodiesterase-4 (PDE4) inhibitor, which plays a significant role Read More » August 26, 2025